Fortrea Holdings Inc. FTRE Clinical Services Segment — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fortrea Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fortrea Holdings Inc.'s clinical services segment — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Fortrea Holdings Inc.'s clinical services segment — revenue?
- Fortrea Holdings Inc. (FTRE) reported clinical services segment — revenue of $636.5M in Q1 2026.
- How has Fortrea Holdings Inc.'s clinical services segment — revenue changed year-over-year?
- Fortrea Holdings Inc.'s clinical services segment — revenue decreased by 2.3% year-over-year, from $651.3M to $636.5M.
- What is the long-term trend for Fortrea Holdings Inc.'s clinical services segment — revenue?
- Over 4 years (2021 to 2025), Fortrea Holdings Inc.'s clinical services segment — revenue has grown at a -0.4% compound annual growth rate (CAGR), from $2.76B to $2.72B.
- What does clinical services segment — revenue mean?
- Represents the total gross income generated by the clinical services business segment through the provision of clinical trial management and related research solutions. This metric reflects the scale of the segment's market activity and its ability to attract biopharma and medical device clients.